Cause and timing of first allograft failure in orthotopic liver transplantation: A study of 177 consecutive patients [PDF]
, 1991 The cause and timing of first liver allograft failure was evaluated in 177 patients who underwent a second liver transplant between January 1984 and December 1988.
Busuttil +22 more
core +1 more source
Heparan sulfate is a plasma biomarker of acute cellular allograft rejection. [PDF]
PLoS ONE, 2018 Despite advances in management of immunosuppression, graft rejection remains a significant clinical problem in solid organ transplantation. Non-invasive biomarkers of graft rejection can facilitate earlier diagnosis and treatment of acute rejection.
Andrew S Barbas +6 more
doaj +1 more source
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies [PDF]
, 1992 Twenty‐six adult patients with preformed IgG donor lymphocytotoxic antibodies received primary liver allografts under FK 506 immunosuppression. The effect of the crossmatch‐positive state on early graft function and on the immunopathological and ...
Batts +40 more
core +1 more source
Improved surgical technique for the establishment of a murine model of aortic transplantation. [PDF]
, 1998 Aortic allotransplantation is a reliable procedure to study the evolvement of chronic rejection in mice. The progressive nature of this process in mice is characterized by diffuse and concentric myointimal proliferation which is inevitably associated ...
Aitouche, A +6 more
core +1 more source
Journal of Transplantation, 2020 Background. The presence of donor-specific antibodies (DSAs) against HLA before kidney transplantation has been variably associated with decreased long-term graft survival.
Michiel G. H. Betjes +5 more
doaj +1 more source
What have we learned about primary liver transplantation under tacrolimus immunosuppression? - Long-term follow-up of the first 1000 patients [PDF]
, 1999 Objective: To summarize the long-term efficacy and safety of tacrolimus in orthotopic liver transplant (OLT) recipients, as well as to examine the factors that influence long-term morbidity and mortality rates. Background: Tacrolimus (FK506, Prograf) was
Abu-Elmagd, K +6 more
core +2 more sources
Interleukin-2 receptor antagonists for pediatric liver transplant recipients: A systematic review and meta-analysis of controlled studies [PDF]
Pediatric Transplantation, 18(8):839-850, 2014, 2014 Interleukin-2 receptor antagonists (IL-2RA) are frequently used as induction therapy in liver transplant recipients to decrease the risk of acute rejection while allowing the reduction of concomitant immunosuppression. The exact association with the use of IL-2RA however is uncertain.
arxiv +1 more source
Non-invasive monitoring of renal transplant recipients: Urinary excretion of soluble adhesion molecules and of the complement-split product C4d [PDF]
, 2003 Background: The number of inducible adhesion molecules known to be involved in cell-mediated allograft rejection is still increasing. In addition, recent data describe complement activation during acute humoral allograft rejection.
Friedrich, N. +5 more
core +1 more source
Anomalous Postselection in the Hensen et al. Bell Test [PDF]
Incorporated into Section 4 of: Open Physics, Volume 15, Issue 1
(Sep 2017), 2016 It is shown that the data of the Hensen et al. Bell test experiment exhibits anomalous postselection that can fully account for the apparent violation of the CHSH inequality. A simulation of a local realist model implementing similar postselection is presented.
arxiv +1 more source
World Journal of Gastroenterology, 2018 AIM To investigate the role of tacrolimus intra-patient variability (IPV) in adult liver-transplant recipients. METHODS We retrospectively assessed tacrolimus variability in a cohort of liver-transplant recipients and analyzed its effect on the ...
A. Del Bello +8 more
semanticscholar +1 more source